MYC and cancer: Recent reports that spliceosome inhibition is more effective against MYC‐driven cancer (Hsu et al, 2015; Koh et al, 2015) persuaded us to validate this preliminary analysis result that MYC‐mutated or MYC‐amplified cancer cell lines were more sensitive.